Nature metabolism · 2026
ALDH1L2 regulates reactive oxygen species and acinar-to-ductal metaplasia in the pancreas.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hennequart Marc, Mervant Loic, Stockis Julie, Coomes Jack, Zarou Martha M, Gerard Louise, Tevel Virginie, Migeot Valérie, Pilley Steven E, Lee Younghwan, Driscoll Paul C, Legrave Nathalie M, Labuschagne Christiaan F, Zani Fabio, Uribe Alejandro Huerta, Ferreira Rute Machado De Morais, Cheung Eric C, Malanchi Ilaria, MacRae James I, Maddocks Oliver D K, Halim Timotheus Y F, Vousden Karen H
Аннотация
Acinar-to-ductal metaplasia (ADM) contributes to pancreatic repair after injury1. However, persistent ADM, combined with KRAS mutation, leads to the development of precancerous pancreatic intraepithelial neoplasia (PanIN) that can progress into pancreatic ductal adenocarcinoma (PDAC)2. While PDAC development is well documented, the metabolic rewiring that occurs during early events such as ADM is poorly understood. Here we show that aldehyde dehydrogenase 1 family member L2 (ALDH1L2), an NADPH-producing mitochondrial enzyme of the one-carbon pathway, limits reactive oxygen species (ROS) and formate production in pancreatic acinar cells. However, ALDH1L2 expression decreases progressively during ADM and is completely absent in pancreatic ductal cells. ALDH1L2 loss elevates ROS and promotes ADM in a model of pancreatitis and accelerates tumour progression in models of pancreatic cancer. We also show that formate increases during PDAC progression in mice and humans. Overall, our findings identify ROS as a driver of ADM and suggest that circulating formate may serve as a biomarker for PDAC progression.